FUJIFILM Strengthens Ultrasound Range with Sonosite MT

FUJIFILM Strengthens Ultrasound Range with Sonosite MT

India Pharma Outlook Team | Friday, 07 November 2025

 FUJIFILM Sonosite, Sonosite MT

The latest portable ultrasound device, Sonosite MT, by FUJIFILM Sonosite, is the addition to the point-of-care product range, PX, LX, and the ST.

The stand provides clinicians with flexibility as the clamshell-like MT can be utilized with or without the stand in all care environments. It is lightweight and small in size; hence, it can be transferred between the departments with ease and is available at all times in a busy hospital.

The system generates high quality and sharp images which aid correct diagnosis of any kind of patient. Its entirely touchscreen interface built into the FUJIFILM Sonosite product line does not require buttons on the monitor and control panel.

Also Read: Unlocking India's Innovation Potential in Pharma

Commenting on the launch, Richard Fabian, President and CEO of FUJIFILM Sonosite, said: “At FUJIFILM Sonosite, our mission is to empower clinicians with ultrasound systems that perform reliably in the most demanding clinical settings. Sonosite MT exemplifies this mission by integrating our core product pillars—durability, reliability, and ease of use. This new system continues our journey of excellence, providing a portable ultrasound platform that supports both clinical confidence and operational efficiency.”

The design will allow the user to clean and disinfect the device faster, ensuring the high standard of infection-control is maintained by the teams. The MT is linked to the Synapse Synchronicity which is a workflow manager of FUJIFILM.

The integration enhances coordination, facilitates the day-to-day work process, and increases the efficiency of operations within the healthcare facilities. FUJIFILM sonosite is distributed in over 100 countries and it is the market leader in the point-of-care ultrasound. The brand will improve cardiovascular diagnosis using advanced diagnostic workflow after its March 2025 collaboration with Us2.ai.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.